Bloomberg Law and Scott Budlong Publish 2018 Edition of Hedge Fund Equity Investing: U.S. Legal Issues

Print PDF
August 13, 2018

RK&O is pleased to announce that the 2018 edition of Hedge Fund Equity Investing: U.S. Legal Issues, written by RK&O partner Scott C. Budlong, has been published by Bloomberg Law® as part of its Securities Practice Portfolio Series.  This newly updated publication focuses on issues related to federal securities law that may apply to hedge funds when buying, holding and selling U.S. equity securities.

The publication is structured into four areas that address recurring issues faced by in-house counsel.  Topics covered include: SEC reporting (Section 13 and Section 16); liquidity issues (Rule 144 public resales, various private resales, short selling and reorg equity); securities regulatory issues (avoiding problems under the SEC’s proxy rules, tender offer rules and anti-market manipulation rules); and legal and issuer-specific limits on equity ownership (the HSR Act, Delaware’s business combination statute and shareholder rights plans).

The updates to the 2018 edition include new content on “group” status under Section 13; the registered investment adviser exemption from Section 16 deemed beneficial ownership; the “investment-only” exemption under the HSR Act; and the structure of modern poison pills.  

Bloomberg Law® portfolios are written by expert practitioners and feature deep-dive analysis and practice tools, such as checklists, charts, forms and other supporting material, on a wide range of key legal topics.  These publications are available online to Bloomberg Law® subscribers. 

To request a hard copy of the 2018 edition of Hedge Fund Equity Investing: U.S. Legal Issues, please email info@rkollp.com.